Streetbeat News

Earnings

BNED

CLDI

SKIL

WISA

Skillsoft Corp. shares fell by 26.7% after reporting mixed Q4 results and lower-than-expected FY25 revenue guidance. Other stocks moved significantly in Tuesday's session, with notable gainers including WiSA Technologies and Palisade Bio, and losers like Barnes & Noble Education and Calidi Biotherapeutics.

Portfolio Pulse from Avi Kapoor

April 16, 2024 | 6:17 pm

ISRG

Deep-pocketed investors have shown a bearish sentiment towards Intuitive Surgical (NASDAQ:ISRG), with a significant move in options trading. Benzinga's tracking revealed 24 unusual options activities, with a bearish majority. The targeted price range for ISRG is between $300.0 and $430.0. Notable options activity includes both bullish and bearish sentiments, with a mix of puts and calls. Intuitive Surgical's current market status shows a slight price increase and a neutral RSI, with earnings expected in 2 days. Analysts from Stifel and Citigroup maintain Buy ratings with target prices of $430 and $462, respectively.

Portfolio Pulse from Benzinga Insights

April 16, 2024 | 6:16 pm

CURLF

MSOS

Boris Jordan, associated with Curaleaf, comments on unexpected real growth in the third quarter, already evident in the first two weeks. He highlights Germany as a bigger market than Florida, emphasizing Curaleaf's strong brand positioning in the cannabis industry.

Portfolio Pulse from Benzinga Newsdesk

April 16, 2024 | 6:15 pm

Benchmark analyst Fawne Jiang maintains a Buy rating on JD.Com, Inc (NASDAQ:JD) with a price target of $55, citing disciplined cost management and healthy GMV growth. The first quarter revenue projection remains unchanged at +6% y/y, with a raised non-GAAP NPM estimate to 2.8%. For FY24, GMV and revenue are expected to grow above China's retail growth rate with a stable profit year over year. The current estimates do not factor in potential stimulus policies from China's government, which could provide an upside to JD's stock.

Portfolio Pulse from Nabaparna Bhattacharya

April 16, 2024 | 6:10 pm

UNH

UnitedHealth Group (NYSE:UNH) reported Q1 earnings with better-than-expected revenue and earnings, despite a cyberattack on its subsidiary Change Healthcare. Adjusted EPS was $6.91, up from $6.26 a year ago, with revenues increasing to $99.8 billion. The company maintained its adjusted EPS guidance of $27.50-$28.00. Goldman Sachs reaffirmed a Buy rating on UNH with a price target of $593, citing a positive medical cost update and prudent outlook. UNH shares rose 5.10% to $468.35.

Portfolio Pulse from Vandana Singh

April 16, 2024 | 6:03 pm

XNCR

Analysts have updated their ratings on Xencor (NASDAQ:XNCR), with 6 recent ratings ranging from bullish to indifferent. The average 12-month price target is now $35.33, down from $45.20, reflecting a 21.84% decline. Analyst actions include lowering price targets and maintaining ratings, indicating a cautious but not entirely bearish outlook on the company. Xencor, a clinical-stage biopharmaceutical company, has shown significant revenue growth and strong financial performance indicators such as net margin and ROE.

Portfolio Pulse from Benzinga Insights

April 16, 2024 | 6:02 pm

MTB

In the last three months, 16 analysts have evaluated M&T Bank (NYSE:MTB), showing a shift towards more bullish and neutral stances compared to previous months. The average 12-month price target for MTB has been raised to $162.38, indicating a positive sentiment shift. Analyst actions include maintaining, raising, and lowering ratings and price targets, reflecting their response to M&T Bank's market conditions and performance. Despite a negative revenue trend and challenges in net margin, M&T Bank's ROE and ROA outperform industry averages, suggesting strong financial management.

Portfolio Pulse from Benzinga Insights

April 16, 2024 | 6:02 pm

IBM

Financial analysts have observed unusual options activity on IBM, indicating a bullish sentiment among significant investors. Analysis of trades shows a preference for calls over puts, with a notable price range target of $155.0 to $230.0 for IBM in the coming three months. The article details specific trades and provides insights into IBM's market position, highlighting its extensive involvement in global IT services and its impact on various sectors. IBM's stock price is currently up 1.62% at $184.19, with an upcoming earnings release in 8 days.

Portfolio Pulse from Benzinga Insights

April 16, 2024 | 6:01 pm

BAC

DIA

QQQ

SPY

TLT

TSLA

Geopolitical tensions and economic forecasts shape market trends, with mixed performances in U.S. stocks and sectors. The IMF's optimistic U.S. growth projection contrasts with potential Middle East escalations. Treasury yields rise, impacting bond ETFs like TLT. Gold nears record highs, while Bitcoin drops. Key stocks and ETFs like SPY, DIA, QQQ, and sector-specific funds XLV and XLE show varied performances. Companies like TSLA, BAC, MS, and others react to news and earnings, influencing their stock prices.

Portfolio Pulse from Piero Cingari

April 16, 2024 | 5:28 pm

GEV

Goldman Sachs analyst Joe Ritchie initiated coverage on GE Vernova Inc (NYSE:GEV) with a Buy rating and a price target of $154, highlighting the company's unique position in electrification and decarbonization. Ritchie emphasized GEV's significant contribution to global electricity supply, its turnaround in the Power business, and the under-estimated growth potential in Wind and Electrification. Despite recent progress, GEV's shares dropped 1.36% to $129.96.

Portfolio Pulse from Shivani Kumaresan

April 16, 2024 | 5:27 pm